Ricky Gervais admits that he always Googles his symptoms
The 63-year-old comedian confessed to researching his symptoms online and jumping to conclusions about the worst-case scenarios
Ricky Gervais has spoken about his health woes, explaining that he's 'reminded every day' of his situation. The 63-year-old comedian said everything is 'sort of slower' and 'aches more', even when just walking downstairs.
Appearing on Jimmy Kimmel Live this week, he also confessed to Googling his symptoms, often leading him to the worst-case scenario. "Now, this is as good as it will ever be, it's not like I'll get better, do you know what I mean?" he said to Jimmy.
"Like they won't go, 'Oh, he's 70 now, he was terrible at 60,' but this is it... I'm reminded every day that I'm getting older. Everything is just sort of slower, aches more.
"When I get up in the morning, right, when I walk downstairs, it's like I've got false legs. Do you know what I mean? Not like false legs today, bionic - like pirate legs. Stiff. It just hurts."
He later added: "What happens is I wake up and I go, 'Oh I've got a lump or a pain' and I go to Jane, 'What do you think that is?' She goes, 'Go to the doctor' and I go 'What, do you think it's serious?' She goes 'No, I don't know'.
"So I Google it, right? Whatever it is... put in the symptoms and the first few are all right. Could be stress, course, could be this, could be diet, and I go, 'Oh that's great, that's great, that's fine, that's fine, that's fine.' And then I just push my luck and number seven [says] cancer. I go 'Jane, I'm dying'."
Ricky certainly isn't alone in these habits. Figures suggest that Brits consulted 'Dr Google' almost 50 million times in 2022, according to Benenden Health. Although it's tempting to self-diagnose this way, experts suggest it may lead to an incorrect result while inducing more panic.
In 2023, Cheryl Lythgoe, Matron at Benenden Health, said: "It's of little surprise to see that physical health is leading the way as one of the most search for health terms, as throughout the COVID-19 pandemic many people have become more conscious of their health. What's concerning is the apparent reliance on Google for this information, possibly leading to an incorrect self-diagnosis or panic.
"When there's a long wait for doctor's appointments it's easy to get impatient and the ability to self-diagnose via the internet can for some be too tempting. If you are looking for advice online, I would recommend visiting trusted sources such as the NHS website as a first port of call to ensure the advice is from experts and more likely to be accurate.
"However at the first signs of illness, it's always best to consult a pharmacist or a GP. This will ensure the correct treatment, if necessary, is sought."
Despite his health fears, Ricky told Jimmy that going to a doctor feels like 'admin' and he'll only do it every 10 years when situations seem especially dire. In fact, he's previously taken matters into his own hands, once dangerously attempting to remove a skin tag from his eyelid at home.
"You know those skin tags you get? ...I had one on my eyelid and it looked f*****, so I cut it off with a pair of nail scissors," he said. "I was gnawing through it with these little nail scissors, and it was bleeding.
"I came downstairs, [I said], 'I'm bleeding,' and [Jane] said, 'What did you do?', I said 'I cut it off'. She went, 'Are you f***ing mad? You could get sepsis.' So, I just sort of got loads of Savlon everywhere."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
2 hours ago
- BBC News
Pharmacists warn drug shortage affecting cancer patients
Pharmacists have warned that "one of the worst" examples of medicine shortages is affecting cancer a pancreatic enzyme replacement therapy (Pert), helps digestion and is required by patients with pancreatic cancer, cystic fibrosis, and chronic pancreatitis. It is thought more than 61,000 patients in the UK need the patients are said to be "skipping meals" to ration their medication due to a shortage of it, according to the National Pharmacy Association (NPA).A Department of Health and Social Care spokesperson said there were "European-wide supply issues" and it was "working closely with industry and the NHS" to mitigate the impact on patients. Without the drug, patients lose weight and strength, which means their ability to cope with treatment such as chemotherapy is experts have predicted shortages continuing until next Department of Health and Social Care has extended a serious shortage protocol for Creon which has already been in place for a year. This indicates concern about shortages of a medicine and allows pharmacists to give patients an alternative - though they argue other drugs are also in short supply.A spokesperson for the department said the "European-wide supply issues" were caused by manufacturing supply constraints. 'Extra layer of stress' The National Pharmacy Association said more than three quarters of members covered in a recent survey felt the current arrangements for managing the shortages were inadequate. Some reported that patients were skipping meals and travelling long distances to get hold of the medication, according to the said it was the "worst stock shortage" they had ever had to deal News highlighted the issue in February after a woman got in touch saying it was impossible for her husband, who has pancreatic cancer, to digest his food without Creon. That month, leading pancreatic clinicians and charities wrote to the prime minister, saying the absence of Pert can have a "devastating impact on people's lives".They called for a national strategy to tackle the from Birmingham was diagnosed with pancreatic cancer in 2023 and initially got 15 boxes of Creon capsules every month to help her tolerate chemotherapy. She can now get only six or seven and is having to skip snacks. The 64-year-old said the shortage had profoundly affected her mental health. She told the BBC: "Each day I'm trying to balance: what shall I eat, shall I have a more substantial meal, shall I take my supplements and that creates an extra layer of stress and worry whilst I'm trying to put my life together again after having this diagnosis." 'Taking desperate measures' Alfie Bailey-Bearfield of Pancreatic Cancer UK said the charity had been raising concerns with the government and suppliers for more than a year and it was vital that officials intervened to try to boost supply."Thousands of people affected by pancreatic cancer rely on taking Pert tablets every time they eat simply to digest their food and absorb nutrients – something most of us take for granted," he said."It's totally unacceptable that they are still taking desperate measures which puts their health, wellbeing and their eligibility for treatment at risk," he Leyla Hannbeck, chief executive of the Independent Pharmacies Association said it was very difficult for her members to obtain supplies from the wholesaler."The shortages with Creon has been ongoing for so long and it seems no effective attempts are being made by officials to make the process easier for pharmacies and patients and to put robust plans in place to prioritise the availability of this product," she said."Instead they continue prolonging the current processes."A Department of Health and Social Care spokesperson said it knew "how frustrating and distressing" medicine supply issues can be for patients and clinicians caring for added: "The European-wide supply issues with Creon are caused by a limited availability of raw ingredients and manufacturing capacity constraints."We are working closely with industry and the NHS to mitigate the impact on patients and resolve the issues as quickly as possible."
The Guardian
4 hours ago
- The Guardian
Spending on agency staff across NHS England drops by almost £1bn
Spending on agency staff across NHS England dropped by almost £1bn in the last financial year, ministers have said, after a pledge by Wes Streeting to cut the amount going to agencies by 30%. According to the Department of Health and Social Care, the total spent by trusts on agency staff during 2024-25 was nearly £1bn lower than the previous year. In a speech to the NHS Providers conference in November, Streeting, the health secretary, said a lack of permanent staff had seen gaps filled by more expensive agency-provided replacements totalling about £3bn a year. Under proposals outlined at the time, but not yet enacted, Streeting suggested that NHS trusts could be completely banned from using agency staff for lower level jobs such as healthcare assistants and domestic support workers. This could also involve stopping NHS staff from resigning and then immediately signing on with an agency, so they can do the same work for higher wages, and a much higher overall cost to the NHS. In addition to employing agency staff, which can mean paying a doctor thousand of pounds for a single shift, NHS trusts also routinely plug gaps by using what are known as 'bank' staff – NHS employees who do extra shifts at their own workplace or one nearby, via an organisation usually run by the trust. UK-wide figures reported by the Guardian in January 2024 showed that the combined spend of hospitals and GP surgeries for agency staff was an annual £4.6bn, with another £5.8bn used for bank shifts. As part of the clampdown on agency spending, Streeting and James Mackey, the chief executive of the imminently abolished NHS England, have jointly written to all NHS providers and integrated care board executives to set out that each should target the 30% reduction, and that their progress will be monitored. 'If we do not feel that sufficient progress is being made by the autumn, we will consider what further legislative steps we should take to ensure that use of agency staff is brought to an end,' they wrote. The letter also says hospital bosses should make surethe pay rates for bank shifts 'are competitive but do not exceed those paid by agencies directly to the worker'. Trusts have already been ordered to reduce bank use by at least 10%. Sign up to First Edition Our morning email breaks down the key stories of the day, telling you what's happening and why it matters after newsletter promotion Elizabeth O'Mahony, NHS England's chief financial officer, said: 'The NHS is fully committed to making sure that every penny of taxpayers' money is used wisely to the benefit of patients and the quality of care they receive. 'Our reforms towards driving down agency spend by nearly £1bn over the past year will boost frontline services and help to cut down waiting lists, while ensuring fairness for our permanent staff.'
NBC News
5 hours ago
- NBC News
FDA grants limited approval to new Covid vaccine from Moderna
Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 and older, as well as people ages 12 to 64 with at least one medical condition that increases their risk for severe Covid. The approval, which is limited to individuals who have previously received a Covid vaccine, was granted by the FDA on Friday. Moderna said in a Saturday press release that the new vaccine should be available in the U.S. in time for the 2025-26 respiratory virus season, which starts in the fall. Moderna is also updating its original vaccine to target the LP.8.1 variant this fall. The company submitted an application in May for the FDA to approve the updated formula. The newly approved vaccine, mNEXSPIKE, contains one-fifth of of Moderna's original Covid vaccine dose, Spikevax. It is intended as an alternative for individuals who prefer a lower-dose option, not as a replacement for existing Covid vaccines. But young, healthy adults won't be eligible to receive it, despite their inclusion in Moderna's clinical trial. The FDA imposed similar limitations on Novavax's Covid vaccine when it approved the shot last month. But Friday marks the first time the FDA has greenlit a vaccine since the Trump administration's call for tighter restrictions on vaccine eligibility and approvals. The FDA said last month that it would limit its approval of updated Covid shots moving forward to older adults and younger people with underlying medical conditions. Health and Human Services Secretary Robert F. Kennedy Jr. also announced last week that the Centers for Disease Control and Prevention would no longer recommend Covid vaccines for healthy children and pregnant women. The CDC website appears to soften that recommendation, suggesting that parents can speak with a doctor about vaccinating children 6 months and older. The Trump administration has also said new Covid vaccines must undergo clinical trials with an inert placebo — meaning some participants would receive the new vaccine while others would receive an inactive substance like saline, to compare results. Many new vaccines are tested against older, approved versions, a method considered to be more ethical since using an inert placebo would mean withholding the benefit of a vaccine from study participants. Moderna's new vaccine was tested this way, using what's known as an 'active comparator.' In a trial of around 11,400 participants ages 12 and up, the new vaccine generated higher antibody levels than the company's original Covid shot, according to Moderna. The company also said the new vaccine had fewer local reactions, which typically include redness or swelling at the injection site. Systemic reactions, which may include fever, headaches or chills, were comparable between the shots. The main side effects of mNEXSPIKE were injection site pain, fatigue, headache and muscle pain, Moderna said in its press release.
